Extracellular signal-regulated kinase 1/2 (ERK1/2) also plays central roles in the anti-apoptotic pathways, proliferation, and drug resistance of HNSCC [4,5]. This evidence concerns the gene MAPK3 and head and neck squamous cell carcinoma.